Catalyst Pharmaceuticals Inc. (CPRX)
NASDAQ · Healthcare
Catalyst Pharmaceuticals Inc. Operating Income 2012–2025
Catalyst Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2012 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Catalyst Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was 73.2 M, a 15.57% increase year-over-year.
- Catalyst Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was 269.2 M, a 183.05% increase year-over-year.
- Catalyst Pharmaceuticals Inc. annual operating income for 2025 was 257.8 M, a 32.11% increase from 2024.
- Catalyst Pharmaceuticals Inc. annual operating income for 2024 was 195.1 M, a 124.77% increase from 2023.
- Catalyst Pharmaceuticals Inc. annual operating income for 2023 was 86.8 M, a 14.75% decrease from 2022.
- Catalyst Pharmaceuticals Inc. annual operating income for 2022 was 101.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Catalyst Pharmaceuticals Inc. Operating Income — FAQ
Catalyst Pharmaceuticals Inc. (CPRX) operating income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Catalyst Pharmaceuticals Inc.'s operating income?
Catalyst Pharmaceuticals Inc. (CPRX) reported operating income of $258M for fiscal 2025.
Where can I see CPRX's operating income history?
The chart and table above show Catalyst Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.